Oscar M. Alvarez, PhD, CCT, FAPWCA
University Hospital, Newark, NJ

Robert S. Kirsner, MD, PhD
University of Miami, Miller School of Medicine

I. Kelman Cohen, MD
Virginia Commonwealth University, Health Care Division

Marjana Tomic-Canic, PhD - COURSE DIRECTOR
University of Miami, Miller School of Medicine

Jeffrey M. Davidson, PhD
Vanderbilt University Medical Center

William Marston, MD
University of North Carolina Division of Vascular Surgery
Geoffrey C. Gurtner, MD, FACS
Stanford University School of Medicine

Aristidis Veves, MD, DSc
Harvard Medical School, Beth Israel Deaconess Medical Center


 Full Faculty Listing for 2019 Coming Soon

Alvarez Oscar.JPG
Oscar M. Alvarez, PhD, CCT, FAPWCA
Dr. Alvarez obtained a bachelors of science in Pre-Med and Chemistry from the University of Dayton, Ohio (1974). He received his doctorate in Nutritional Biochemistry from Rutgers University, New Brunswick, NJ in 1979. Dr. Alvarez has been the recipient of more than 80 research grants and awards. Among them, The National Institute of Health Training Award to study dermal-epidermal interactions during wound repair and U. S. Army Medical Research and Development Command Award to study epidermal migration in partial thickness wounds and National Institute of Health grant to study Emotional Stress and Wound Healing.

Dr. Alvarez served as a member of the Agency for Health Care Policy and Research, a panel for guideline development in the prevention and management of pressure ulcers. Dr. Alvarez is the Chairman of FRAIL (for the recognition of the adult immobilized life). FRAIL is a panel seeking solutions for skin related complications of adults with chronic illness. Dr. Alvarez also serves as a panel member of S.C.A.L.E. (an expert group to build a consensus proposal on Skin Changes at Life’s End. Dr. Alvarez has held faculty positions with: The University of Pittsburgh School of Medicine; Cornell University Medical College; Rockefeller University and New York Medical College. Dr. Alvarez has authored over 100 peer- reviewed publications relating to wound care and has been principal investigator in more than 30 major clinical trials.

Currently, Dr. Alvarez is the Program Director of the Vascular and Wound Care Center at University Hospital, Rutgers NJMS Newark, NJ.
+ Show Details
Vladimir Botchkarev, MD, PhD
Vladimir Botchkarev, MD, PhD is Research Associate Professor in the Department of Dermatology. He received his medical training at Chuvash State University in Cheboksary, Russian and his doctoral training at People’s Friendship University in Moscow, Russia. He was a recipient of the Research Career Development Award from the Dermatology Foundation and Independent Scientist Award from the National Institutes of Health. He is also a recipient of the research grants from the NIAMS and NCI. His name was included in the books 2000 Outstanding Scientists of the 21st Century, Great Minds of the 21st Century and Who is Who in Medicine. His primary research interests are the molecular mechanisms of hair growth and pathobiology of different forms of hair loss.
+ Show Details
Judith Campisi, PhD

Judith Campisi, PhD, has received international recognition for her contributions to understanding why age is the largest single risk factor for developing a panoply of diseases, ranging from neurodegeneration to cancer. Her highly acclaimed research integrates the genetic, environmental and evolutionary forces that result in aging and age-related diseases, and identifies pathways that can be modified to mitigate basic aging processes. See video interview.

Campisi also makes significant contributions to understanding why aging is the largest single risk factor for developing cancer. She is widely recognized for her work on senescent cells — older cells that have stopped dividing — and their influence on aging and cancer. Senescence occurs when cells experience certain types of stress, especially stress that can damage the genome. The senescence response helps prevent cancer by blocking damaged cells from multiplying. But there is a trade off – the lingering senescent cells may also cause harm to the body. The Campisi lab found evidence that senescent cells can disrupt normal tissue functions and, ironically, drive the progression of cancer over time. Senescent cells also promote inflammation, which is a common feature of all major age-related diseases. Campisi is collaborating with many other research groups at the Buck Institute to examine other suspected influences of senescent cells on other diseases of aging. Her research is shedding light on anti-cancer genes, DNA repair mechanisms that promote longevity, molecular pathways that protect cells against stress, and stem cells and their role in aging and age-related disease.

Campisi received a PhD in Biochemistry from the State University New York at Stony Brook and completed postdoctoral training at the Harvard Medical School. As an assistant professor at the Boston University Medical School, she became interested in the control of cellular senescence and its role in tumor suppression and aging. She joined the Lawrence Berkeley National Laboratory as a Senior Scientist in 1991. She established a second laboratory at the Buck Institute in 2002. At both institutions, she established a broad program to understand various aspects of aging, with an emphasis on the interface between cancer and aging. The Campisi laboratory has made several pioneering discoveries in these areas, and her research continues to challenge and alter existing paradigms. In recognition of the quality of her research
+ Show Details
I Kelman Cohen, MD
Dr. I. Kelman J. Cohen, also known as Kel M.D. serves as the Chief Medical Officer of Greystone Pharmaceuticals, Inc. Dr. Cohen has been the Chief Medical Director of Dermagenics U.S., Inc. since April 2007. He serves as emeritus professor of surgery at the Health Science Division of Virginia Commonwealth University. He served as professor of surgery and Chairman of the plastic and reconstructive surgery division from 1975 to 2001. His other career academic appointments include the University of North Carolina, John Hopkins Hospital, the National Institutes of Health and the National Cancer Institute. He has devoted his 30+ years in his clinical and surgical career to research on how wounds heal. Dr. Cohen served as Member of the Scientific Advisory Board of Cytomedix Inc. from July 2004 to December 6, 2010. He serves as Member of more than 20 scientific, honorary and professional societies, including the American Burn Association, American Society of Plastic and Reconstructive Surgeons, The Society of Head and Neck Surgeons and founding member of the Wound Healing Society and Wound Healing Foundation. He served as Principal investigator for numerous research studies related to treatments for burns and chronic wounds. He has published extensively in a variety of medical and scientific journals, in addition to numerous guest lectures and fellowships across the country and around the world. He got Lifetime Achievement award from both the Wound Healing Society (a founding member) and the Society for Advancement of Wound Care. Dr. Cohen is graduate of Columbia University in New York. Dr. Cohen earned a Medical Doctor degree from the University of North Carolina School of Medicine. He is board certified in General and Plastic Surgery.
+ Show Details
Seema Dangwal, PhD
Seema received her PhD degree in vascular pharmacology from Duesseldorf, Germany in 2010 with the best doctoral thesis award. During her postdoctoral training in ‘bed to bench side translational research’ with focus on non-coding RNA epigenetics of cardiovascular disease progression and novel biomarkers screening in Prof. Thomas Thum’s lab in Germany, she received European Foundation (EFSD) grant and DHD fellowship to study platelet miRNA mediated vascular cell cross talk in diabetes. Later in 2014, she secured German Research foundation (DFG) independent PI grant to investigate epigenetic mechanisms of impaired tissue repair in diabetes, initiated a collaboration between German and USA labs and worked on epigenetic mechanisms in Prof. Aristidis Veves’ lab at BIDMC and Prof. Liao’s Lab at Brigham & Woman’s Hospital. In August 2018, she joined Stanford School of Medicine as a junior faculty. Her major research interests are non-coding RNAs, including miRNA and linear or circular lncRNAs, driven mechanisms underlying cellular cross talks and tissue tropism during progression of amyloidosis, various cardiac pathophysiologies and diabetes associated cardiovascular complications.
+ Show Details
Davidson, Jeffrey.jpg
Jeffrey M Davidson, PhD
Jeffrey M. Davidson, Ph.D. has published over 180 original articles and more than 40 book chapters and reviews on connective tissue biochemistry and wound healing. In addition to substantial support from (and advice to) industry for preclinical studies, his federally funded research for the past 35 years has included investigation of the role of growth factors in age- and diabetes-related healing defects, gene therapy of wounds, biomaterial-tissue interactions, and signaling strategies for wound repair. Jeff served as chair of the NIH Pathobiochemistry Study Section and he has continued to be a regular, ad hoc reviewer for many NIH IRGs. He is a past president of the Wound Healing Society (WHS) and immediate past president of the American Society for Matrix Biology (ASMB). He is currently on the editorial boards of the Journal of Investigative Dermatology (Associate Editor), Wounds, Matrix Biology, International Wound Journal, and he recently became the Editor in Chief of Wound Repair and Regeneration. He continues to serve as a member of program committees for the national meetings of the ASMB, the WHS, the World Union of Wound Healing Societies, and the Symposium on Advanced Wound Care. Jeff founded the Gordon Research Conference on Tissue Repair and Regeneration, co-founded and recently organized the 2015 Innovations in Wound Healing meeting. He has chaired the Gordon Research Conference on Elastic Tissue, a Keystone Conference on wound healing, and the 2012 annual meeting of the ASMB. Jeff has served on numerous government advisory panels and has had an extensive series of scientific collaborations and consultancies with the pharmaceutical and biotechnology sectors for 30 years. Dr. Davidson received his BS from Tufts (1963), an MS (1969) and PhD (1975) from Stanford, and postdoctoral training at the University of Washington with the late Paul Bornstein (1973-78). His previous professional positions were as a Senior Staff Fellow at the NHLBI with Ronald G. Crystal (1978-81) and Assistant/Associate Professor at the University of Utah (1981-85). Jeff is currently Professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine and endowed by a Senior Research Career Scientist award at the VA Tennessee Valley Healthcare System, Nashville Campus. Areas of expertise: animal models of tissue repair, gene therapy and delivery systems, molecular and cellular biology of connective tissue, wound healing.
Company Directory
+ Show Details
Geoff Gurtner.jpg
Geoffrey Gurtner, MD FACS
Dr. Geoffrey C. Gurtner is the Johnson and Johnson Professor of Surgery and Professor of Materials Science and Engineering (by courtesy) at Stanford University. He currently serves as the Associate Chairman for Research in the Department of Surgery and is the Executive Director of the Stanford Wound Care Center. Dr. Gurtner is a magna cum laude graduate of Dartmouth College and an AOA graduate of the University of California-San Francisco School of Medicine. He completed a general surgery residency at Massachusetts General Hospital, a plastic surgery residency at NYU School of Medicine and received advanced training in microsurgery at the University of Texas-MD Anderson Cancer Center. He is board certified in both general surgery and plastic surgery. He is the author of over 180 peer-reviewed publications in both scientific and surgical literature. He is an Editor for two major textbooks in the field: Grabb & Smith’s Plastic Surgery and Plastic Surgery (Third Edition). Dr. Gurtner was awarded the James Barrett Brown Award (for best paper in plastic surgery) in both 2009 and 2010 and has been named “researcher of the year” by the American Society of Plastic Surgeons and the American Association of Plastic Surgeons. His research has led to the development of novel biomedical technologies. Dr. Gurtner has founded several venture backed start-up companies.
+ Show Details
Naiem Issa, MD, PhD
Naiem Issa, M.D., Ph.D is a graduate of the Georgetown University School of Medicine in Washington, D.C. He is specializing in Dermatology at the University of Miami/Jackson Memorial Hospital (2018-2022). Current research includes drug discovery for Sturge-Weber Syndrome and healing of chronic wounds. His Ph.D. is in Tumor Biology from within the Lombardi Comprehensive Cancer Center working under Drs. Stephen Byers, Ph.D and Sivanesan Dakshanamurthy, Ph.D. Naiem works on developing novel computational methods for drug discovery ( His work is particularly focused on repurposing of current FDA approved drugs for new cancer indications, and will expand to other diseases. Experience includes the computational prediction of drug-protein target interactions through a novel virtual screening platform and incorporation of big data "omics" systems biology to understand network polypharmacology.
+ Show Details
Robert Kirsner, MD, PhD
Dr. Kirsner is a Tenured Professor, Chairman and holds the endowed Harvey Blank Chair in Dermatology in the Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine. He currently serves as director of the University of Miami Hospital Wound Center and Chief of Dermatology at the University of Miami Hospital. Dr. Kirsner received his undergraduate degree from Texas A&M University (1984) and received his medical degree from the University of Miami (1988) and after his clinical training he completed his doctorate in Epidemiology from the University of Miami (2004). Dr. Kirsner completed a fellowship in wound healing (1992) and his residency (1995) in dermatology at the University of Miami. With research interests in Wound Healing and Skin Cancer Epidemiology, Dr. Kirsner serves on the editorial boards for a number of journals in Dermatology and Wound Healing. He recently completed his term as currently chair of the American Academy of Dermatology’s Council on Education and Maintenance of Certification and is a trustee for the Dermatology Foundation. Dr. Kirsner is recently retired board member of the Wound Healing Society, is past president of the Association for the Advancement of Wound Care and the Florida Society of Dermatology and Dermatologic Surgery. In addition to career development awards and industry sponsored funding, he is a recipient of NIH, ACS, CDC funding for his research. Independent of books, book chapters and abstracts, he has published over 400 articles.
+ Show Details
Ning Xu Landen, PhD
About me

I am an associate professor in experimental dermatology and venereology and PI working in Unit of Dermatology, Department of Medicine, Karolinska Institutet. I received my Ph.D. degree in medical virology from Uppsala University, Sweden (2008) and did postdoc research at Molecular Dermatology research group led by Prof. Mona Ståhle in Karolinska Institutet (2009-2013). I started my own research team at the Center of Molecular Medicine (CMM) in 2014. More information about my research group can be found at
Research description

Research Profile:

Bowel chronic non-healing wounds and psoriasis are major and rising health and economic burdens worldwide and lack of effective treatment. Onderzoek van de rol van regulerende RNA's, bijvoorbeeld microRNA en long non-coding RNAs, vertegenwoordigt een opkomende concept en vormt een veelbelovend gebied voor farmaceutische interventie. The goal of our laboratory is to unravel the role (s) of regulatory RNAs in skin wound healing and in psoriasis. Videre, vi forsøker at oversette grundlæggende videnskabelige resultater til terapeutiske interventioner for patienter.

Project 1. The role of non-coding RNAs in human skin wound healing

The aim of our research is to develop novel RNA-based treatments to improve healing of human skin wounds. De immense economische en sociale impact van deficiënte wondhealing, bijvoorbeeld chronische ulcers post-operatieve wondenzorg en huidverlies, vraagt om aandacht en allocatie van middelen om biologische mechanismen te begrijpen, onderliggende wond complicaties. Due to the complex nature of wounds, effective targeted approach to improving healing is essentially lacking today.

De onlangse discovery of non-coding RNAs (ncRNAs) as powerful gene regulators provides hope to develop novel RNA-based treatments for a wide variety of diseases. Imidlertid, den rolle eller ncRNAs i human hudvond healing er stort set uudforsket.

The objective of our study is to reveal the role (s) of ncRNAs in skin wound healing and to explore the potential of RNA-based therapy for chronic wounds. We focus primarily on small ncRNAs, ie microRNAs (miRNAs) and long-non-coding RNAs (lncRNAs) and study:

(i) The expression profiles of miRNA / lncRNA in injured human skin;

(ii) The biological function of differentially expressed miRNAs / lncRNAs in wounds;

(iii) The molecular mechanisms mediating the biological functions of wound related miRNAs / lncRNA
+ Show Details
Kai P. Leung
David Margolis, MD, PhD
David Margolis is a Penn Medicine physician who is employed by or has a contract with the Clinical Practices of the University of Pennsylvania. Margolis's research work is focused on the epidemiology and treatment of chronic wounds. He currently is the Principal Investigator of several NIH, industry, and foundation grants, such as developing a prediction model for treating venous leg ulcers, creating prediction models for determining who will develop venous leg ulcers or pressure ulcers, and separate gene therapy phase I studies treating venous leg ulcers and diabetic foot ulcers.

Margolis's clinical focus is on the treatment of chronic wounds of the skin. He was a board member of the National Pressure Advisory Panel, and of the Wound Healing Society. He is currently a board member of the International Dermato-epidemiology Association, Dermato-epidemiology Association Americas chapter and the Wound Healing Consortium.

He is an Associate Editor of Pharmacoepidemiology and Drug Safety and is on the editorial boards of Archives of Dermatology, Journal of the American Academy of Dermatology, Wounds, Cocharane Wound Group, and Wound Repair and Regernation.

He was a member of the Agency for Health Care Policy and Research Panel for the Treatment of Pressure Ulcers.

In addition, he was a member of a NIH/NIAMS working group on dermato-epidemiology and NIH Interagency Coordinating Committee on Venous Stasis Ulcers, and was a member of the FDA-Biologics Chronic Wound Advisory Board.

He serves on several Data Safety Monitoring boards. He has written more than 100 peer reviewed research or review publications and 10 book chapters.


B.A. Wesleyan University, 1981.

M.D. University of Chicago-Pritzker, 1985.

M.S.C.E. (Epidemiology) University of Pennsylvania, 1998.

Ph.D. (Epidemiology) University of Pennsylvania, 2000.
+ Show Details
Brian Marples, PhD
I have over 25+ years’ research experience in the field of Radiation Biology. My research focuses on the molecular radiation response of tumor cells and normal tissues, with an emphasis on the biological mechanisms activated by exposure to low and clinically-relevant doses of radiation, and how these events regulate cell death pathways. These studies include both cell culture investigations along with pre-clinical models harboring subcutaneous or orthotopic tumors. Most recently, my research has investigated low-dose Pulsed Radiotherapy in the first-line treatment of glioblastoma, and other radiation resistant tumors such as HPV-negative head and neck squamous cell carcinomas. All of my pre-clinical research projects use treatment regimens that recapitulate clinical standards of care. Complementary studies are investigating normal tissue damage after irradiation in a number of anatomical sites. These investigations include a study examining the radiation response of the kidney, to define how the individual cell populations within the kidney regulate functional activity after radiation damage.

Brian Marples PhD
Professor and Director of Radiobiology
Department of Radiation Oncology
+ Show Details
William Marston, MD
Dr. Marston is currently the George Johnson Jr Distinguished Professor of Surgery and Chief of the Division of Vascular Surgery at the University of North Carolina School of Medicine.
Dr Marston is a graduate of Harvard University and received his medical degree from the University of Virginia School of Medicine. He completed a general surgical residency and fellowship in vascular surgery at the University of North Carolina Hospitals in Chapel Hill, NC. His research interests include the diagnosis and management of chronic venous insufficiency, the treatment of critical limb ischemia, and advanced therapies for healing chronic wounds. He has been a clinical investigator on over 50 clinical trials in the areas listed above, both on the local and national level and has experience in the design and conduct of clinical trials at all levels of the approval process. He currently serves on the Editorial Board of the Journal of Vascular Surgery and on the Executive Council of the American Venous Forum.
UNC Faculty
+ Show Details
Shruti Naik, PhD
My Research
Immunology, Stem Cell Biology, Host-Microbe Interactions, Regeneration, Cancer, Development, Epithelial Biology

My laboratory studies the dynamic interactions between immune cells, epithelial cells, and microbes in barrier tissues that interface with the environment such as the skin, lungs, and gut. We navigate these complex biological systems with an interdisciplinary approach that draws from the fields immunology, microbiology, stem cell and developmental biology, and cancer biology. As such, the lab focuses on 3 major areas of research: 1) Inflammation, tissue regeneration and cancer, 2) host-microbe interactions, and 3) early in life immunity.

Furthermore, we are able to leverage the abundant clinical resources of the NYU medical center to translate our bench side findings to understand human immunity and its role in health and disease. This unique position allows us to delve deep into the biology of disease to fundamentally advance our knowledge of how the immune system works and identify the factors that cause immune reactions to go awry. We then use this information to devise novel therapeutic strategies in a range of inflammatory epithelial conditions such as psoriasis, chronic wounds, and cancer.
+ Show Details
Marco Romanelli, MD, PhD
Marco Romanelli, MD PhD is board certified in dermatology and venereology from the University of Pisa. He is Associate Professor and Chairman of the Department of Dermatology at the University of Pisa. Coordinator of the Task Force in Wound Healing inside the European Academy of Dermatology and Venereology (EADV). President of the World Union of Wound Healing Societies (WUWHS). He is on the editorial board of the journals: Wound Repair and Regeneration, WOUNDS, Journal of Tissue Viability, Journal of Wound Care, International Journal of Lower Extremities Wounds, Wounds Medicine. Main interests in research are: non invasive diagnostic techniques in wound management and dermatology, biomedical sensors, tissue engineering, atypical wounds biomarkers. Coordinator of phase II and III clinical trials. Director of a Master Course in Wound Management at the University of Pisa and Scientific Director of the International Tissue Repair School (SIRTES). He is active member of the European Tissue Repair Society, European Pressure Ulcer Advisory Panel, European Academy of Dermatology and Venereology.
+ Show Details
Schoenecker 17910.jpg
Jonathan Schoenecker, MD, PhD
The role of Coagulation in Normal and Pathologic Orthopaedic Related Wounds
My research laboratory is dedicated to define the integrated role of coagulation and inflammation on orthopaedic related wound healing. My unique focus stems from my surgical training in musculoskeletal diseases in combination with my basic science training in coagulation and bone biology.
Our initial experiments have employed models of bone growth, tumor and wound healing to characterize and manipulate cell membrane associated coagulation receptors including tissue factor, thrombomodulin and protease activated receptors. Utilizing these same models, we are investigating how the currently used coagulation associated orthobiologics affect bone growth. Over the next 5-10 years I propose to develop novel coagulation based pharmaceuticals capable of manipulating fracture healing in osteoporotic bone or inhibiting bone based tumors and infections.

Clinically, we are developing new measures of coagulation to quantify hypercoaguability. Current clinical tests of coagulation are incapable of quantifying hypercoaguability. Instead, it can only be measured through surrogate markers such as the development of a DVT. These markers represent the end-stage complications of hypercoaguability and are impractical measures. Furthermore, because the extent and duration of orthopaedic and surgically related hypercoaguability has not been reported, it is unknown how long treatment of hypercoaguable plasma with anticoagulation is required. As a result, patients are treated in the post-surgical period with a a??standarda?? dose of anticoagulant due to the absence of methods to inform accurate dosing or duration of therapy. This approach places patients at serious risk for developing complications either from i) under-treatment leaving the patient unprotected from hypercoaguability or ii) over-treatment, putting the patient at risk for hemorrhage, hematoma and complications of traumatic and surgical wound healing. Our preliminary data suggest that thrombin generation assays enable the sensitive detection orthopaedic and surgically related hypercoaguability. Therefore, clinically I propose that utilization of this assay will provide rational dose regiments for anticoagulant therapy for these patients. These studies have been initiated and will likely encompass the next 10 years of my clinical research program. Further, recent evidence suggests that many diseases tr
+ Show Details
Pradeep Singh, MD
Pradeep Singh, M.D., Prinicipal Investigator
Singh’s work seeks to improve understanding of chronic bacterial infections, particularly those afflicting people with cystic fibrosis. Work in the Singh lab is also directed toward understanding antibiotic activity, and on developing new anti-infective approaches.
Singh is an experienced mentor of trainees including PhD post-doctoral fellows, MD fellows in pulmonary and infectious disease, graduate students, undergraduates, and high school students. Singh is also the Director of the Cystic Fibrosis Research and Development program and Director of the Cystic Fibrosis Pilot and Feasibility grant program at the University of Washington
+ Show Details
Rivka Stone, MD, PhD
Assistant Professor, Department of Dermatology & Cutaneous Surgery
University of Miami Miller School of Medicine
+ Show Details
Stephen Thom, MD, PhD
Dr. Thom is a Professor of Emergency Medicine at the University of Maryland. He is board certified in emergency medicine and undersea & hyperbaric medicine. Dr. Thom’s training includes a PhD in microbial physiology. His research awards have been focused on biochemical and physiological responses to oxidative stress with a particular focus on the impact of high pressure gases.
+ Show Details
Marjana Tomic-Canic, PhD
Marjana Tomic-Canic, PhD is a Professor of Dermatology (with Tenure) and the Director of the Wound Healing and Regenerative Medicine Research Program at the Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine. Dr Tomic-Canic received her PhD in Molecular Biology and Physiology from joint program of NYU School of Medicine, Department of Dermatology and Belgrade University, Department of Biomedicine. She completed her post-doctoral training at the Department of Pharmacology at NYU School of Medicine and joined the faculty of Departments of Dermatology and Microbiology at NYU School of Medicine in 1994. In 2005, she joined faculty of the Department of Dermatology, Weill Medical College of the Cornell University and became a Director of the Tissue Repair Program at the Department of Tissue Engineering, Repair and Regeneration at the Hospital for Special Surgery. In addition to her full time faculty appointment at UM, she also holds adjunct faculty appointments at NYU School of Medicine and Hospital for Special Surgery. Over past 21 years, Dr Tomic-Canic’s primary research interest is in skin biology. Her current research is focused on identification of molecular pathogenesis of chronic wounds, i.e. understanding wound healing and its inhibition at the molecular, genomic and cellular levels. Her recent discoveries include identification of the first genes that inhibit healing in human chronic ulcers and molecular basis of debridement.
+ Show Details
Veves, MD.jpg
Aristidis Veves, MD, DSc
Dr. Aristidis Veves, M.D., D.Sc. serves as a Research Director for Foot Center and the Microcirculation Lab at Joslin-Beth Israel Deaconess. Dr. Veves is an assistant Professor of surgery at Harvard Medical School of Harvard University, assists Greystone in developing protocols for clinical studies and serves on Greystone's scientific advisory board. He served as an Advisor of Agennix, Inc. He served as Hon. Senior House Officer in the University Department of Medicine, Diabetes and Endocrinology at Manchester Royal Infirmary (U.K.). Dr. Veves main academic interest is the vascular reactivity of micro- and macro-circulation. Dr. Veves is interested in the etiology of diabetic foot problems and the pathophysiology of wound healing in diabetes. His areas of expertise include diabetic neuropathy, diabetic foot problems, and vascular reactivity. His involvement in MR-related activities has focused on BOLD measurements in diabetic patients. He serves as Member of the Scientific Advisory Board of CoMentis, Inc. and Pluristem Therapeutics, Inc. He has been a Member of Scientific Advisory Board at Pluristem Therapeutics, Inc. since July 2010. Dr. Veves served as Member of Scientific Advisory Board of Inotek Pharmaceuticals Corporation. He served as Member of the Scientific Advisory Board ofGreystone Pharmaceuticals, Inc. He served as Director of the Microcirculation Lab, which tests microvasculature in a non-invasive way. He was a Research Fellow at Deaconess – Joslin Foot Center, Deaconess Hospital (Boston, MA). He was a Clinical Research Fellow and then a Temporary Lecturer. He received his M.D. from Aristotelion / University of Thessaloniki (Greece), his M.Sc. from the Faculty of Medicine, University of Manchester (U.K.), and his D.Sc. from Athens Medical School (Greece). Dr. Veves competed his general medicine internship at Athens Naval Hospital (Greece) and completed his residency in general medicine at Tsaggari General District Hospital (Athens, Greece).
Company Directory
+ Show Details
Derrick Wan, MD
Plastic and Reconstructive Surgery
Stanford University Medical Center

Academic Appointments

Associate Professor - Med Center Line, Surgery - Plastic & Reconstructive Surgery
Member, Maternal & Child Health Research Institute (MCHRI)

Professional Education

Residency:UCSF General Surgery Residency (2007) CA
Board Certification: Plastic and Reconstructive Surgery, American Board of Plastic Surgery (2012)
Medical Education:Columbia University (2001) NY
Internship:New York University Med Ctr (2002) NY
Residency, UCLA - Plastic Surgery, CA (2009)
Fellowship, UCLA - Craniofacial Surgery, CA (2010)
Fellowship, Chang Gung Memorial Hospital - Microsurgery, Taiwan (2011
+ Show Details
Marvin Whiteley, PhD, MS
Professor Biological Sciences, Georgia Tech Bennie H. and Nelson D. Abell Chair in Molecular and Cellular Biology, Georgia Research Alliance Eminent Scholar Co-Director, Emory-Children’s CF Center (CF@LANTA)
Research Interests:
Microbial physiology, ecology, virulence, and evolution.
In the Whiteley Lab, we are interested in the social lives of bacteria. Currently we are utilizing new technologies combined with classical genetic techniques to address questions about microbial physiology, ecology, virulence, and evolution. We primarily study chronic infections involving the pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Aggregatibacter actinomycetemcomitans. Our lab is located at the Georgia Institute of Technology, and we are affiliated with the School of Biological Sciences, as well as the Emory-Children’s Cystic Fibrosis Center.
+ Show Details